This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Dermatol. 1994;130(3):288.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CHLAMYDIA trachomatis infections are common in sexually active adolescents and young adults in the United States (CDC, unpublished review). More than 4 million chlamydial infections occur annually. Infection by this organism is insidious—symptoms are absent or minor among most infected women and many men. This large group of asymptomatic and infectious persons sustains transmission within a community. In addition, these persons are at risk for acute illness and serious long-term sequelae. The direct and indirect costs of chlamydial illness exceed $2.4 billion annually.^*

Until recently, chlamydia prevention and patient care were impeded by the lack of suitable laboratory tests for screening and diagnosis. Such tests are now available. Through education, screening, partner referral, and proper patient care, public health workers and health-care practitioners can combine efforts to decrease the morbidity and costs resulting from this infection.

ANTIMICROBIAL REGIMENS

Recommendations for the treatment of genital chlamydial infections have been published (146, 156). . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?